VEGF siRNA treatment may have minimal side effects as compared to other anti-VEGF drugs, such as mAbs and small molecule TKIs, which have significant adverse symptoms (bleeding, neutropenia, hypertension, skin problems, and diarrhea). Here, VEGFA is linked to hypertensive disorder.